Form 8-K - Current report:
SEC Accession No. 0001553350-24-000088
Filing Date
2024-09-23
Accepted
2024-09-23 09:00:08
Documents
16
Period of Report
2024-09-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 35779
2 PRESS RELEASE toi_ex99z1.htm EX-99.1 5842
3 GRAPHIC image_002.jpg GRAPHIC 1995
  Complete submission text file 0001553350-24-000088.txt   278082

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE toi-20240919.xsd EX-101.SCH 3912
5 XBRL DEFINITION FILE toi-20240919_def.xml EX-101.DEF 30211
6 XBRL LABEL FILE toi-20240919_lab.xml EX-101.LAB 37033
7 XBRL PRESENTATION FILE toi-20240919_pre.xml EX-101.PRE 27234
18 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 6174
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 241314796
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)